[go: up one dir, main page]

WO2006003587A3 - Formes posologiques solides pour administration orale a base de derives azabicyclo - Google Patents

Formes posologiques solides pour administration orale a base de derives azabicyclo Download PDF

Info

Publication number
WO2006003587A3
WO2006003587A3 PCT/IB2005/052104 IB2005052104W WO2006003587A3 WO 2006003587 A3 WO2006003587 A3 WO 2006003587A3 IB 2005052104 W IB2005052104 W IB 2005052104W WO 2006003587 A3 WO2006003587 A3 WO 2006003587A3
Authority
WO
WIPO (PCT)
Prior art keywords
dosage forms
oral dosage
solid oral
solid dosage
azabicyclo derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2005/052104
Other languages
English (en)
Other versions
WO2006003587A2 (fr
Inventor
Korlapati Venkateswara Rao
Pradeep Jai Rao Karatgi
Ayanampudi Sri Rama Murthy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of WO2006003587A2 publication Critical patent/WO2006003587A2/fr
Publication of WO2006003587A3 publication Critical patent/WO2006003587A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des formes posologiques solides pour administration orale d'un dérivé azabicyclo ou de solvates, esters, énantiomères, diastéréo-isomères, N-oxydes, polymorphes et métabolites de celui-ci, acceptables d'un point de vue pharmaceutique, ainsi que des procédés pour préparer de telles formes posologiques solides. Lesdites formes posologiques solides sont caractérisées en ce qu'elles présentent une très bonne uniformité de teneur.
PCT/IB2005/052104 2004-07-01 2005-06-24 Formes posologiques solides pour administration orale a base de derives azabicyclo Ceased WO2006003587A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1234DE2004 2004-07-01
IN1234/DEL/2004 2004-07-01

Publications (2)

Publication Number Publication Date
WO2006003587A2 WO2006003587A2 (fr) 2006-01-12
WO2006003587A3 true WO2006003587A3 (fr) 2006-09-14

Family

ID=35124429

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/052104 Ceased WO2006003587A2 (fr) 2004-07-01 2005-06-24 Formes posologiques solides pour administration orale a base de derives azabicyclo

Country Status (1)

Country Link
WO (1) WO2006003587A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1618091A1 (fr) 2003-04-09 2006-01-25 Ranbaxy Laboratories, Ltd. Derives d'azabicyclo hexane substitues en tant qu'antagonistes de recepteurs muscariniques
WO2006117754A1 (fr) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited Derives d'azabicyclo [3.1.0] hexane 3,6-disubstitues utilises comme antagonistes du recepteur muscarinique
RU2008119323A (ru) * 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Фармацевтические композиции мускаринового рецептора
US20100152269A1 (en) * 2006-12-21 2010-06-17 Ranbaxy Laboratories Limited Modified-release formulations of azabicyclo derivatives

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004005252A1 (fr) * 2002-07-08 2004-01-15 Ranbaxy Laboratories Limited Derives azabicyclo utilises comme antagonistes des recepteur muscariniques

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004005252A1 (fr) * 2002-07-08 2004-01-15 Ranbaxy Laboratories Limited Derives azabicyclo utilises comme antagonistes des recepteur muscariniques

Also Published As

Publication number Publication date
WO2006003587A2 (fr) 2006-01-12

Similar Documents

Publication Publication Date Title
WO2007135527A3 (fr) Composés de benzimidazolyle
WO2006011050A3 (fr) Derives de pyridine
EP1740156B8 (fr) Procede de production d'une forme galenique solide protegee contre un usage detourne
WO2007042035A3 (fr) Therapie de combinaison pour le traitement d'un trouble auto-immun et/ou inflammatoire et de conditions associees
UA84726C2 (ru) Производные простагландинов, способ их получения, фармацевтическая композиция (варианты) и способ лечения глаукомы или гипертензии глаза
WO2007087548A3 (fr) Composés chimiques
WO2006067614A3 (fr) Derives heteroaromatiques utiles en tant qu'agents anticancereux
WO2009085990A3 (fr) Procédés de préparation de sitagliptine et sels pharmaceutiquement acceptables de celle-ci
WO2006086562A3 (fr) Derives de phenylazetidinone
WO2008027542A3 (fr) Composés d'isoindoline substituée en 5
NZ602266A (en) Macrocycles as factor xia inhibitors
WO2008012622A3 (fr) Composés d'azabenzimidazolyle
WO2009066326A3 (fr) Procédé amélioré pour la préparation de prasugrel et de ses sels pharmaceutiquement acceptables
MX2009008540A (es) Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina.
WO2008006795A3 (fr) Composés d'indole
WO2010070449A3 (fr) Laquinimode très pur ou sel pharmaceutiquement acceptable de celui-ci
WO2005094810A3 (fr) Nouvelles compositions pharmaceutiques
WO2005080352A3 (fr) Derives de quinazoline et leur utilisation therapeutique
WO2005086656A3 (fr) Derives d'heteroarylaminopyrazole utilises pour traiter le diabete
NO20080033L (no) Kinolinderivater som NK3-antagonister
WO2007070433A3 (fr) Derives de 2-arylthiazole en tant que modulateurs du recepteur cxcr3
WO2009056707A8 (fr) Dérivés de l'ind0l-2-0ne disubstitues en 3, leur preparation et leur application en thérapeutique
WO2005105753A3 (fr) Derives naphthalimides, procedes de fabrication et compositions pharmaceutiques les renfermant
WO2008038092A3 (fr) Pipéridinophényloxazolidinones substituées
WO2004111047A3 (fr) Cycloalkanepyrrolopyridines utilisees comme antagonistes du recepteur dp

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 722/DELNP/2007

Country of ref document: IN

122 Ep: pct application non-entry in european phase